Dr. Stephen Andrew Blakely, MD

Dr. Blakely practices at Upstate University Hospital in Syracuse, New York, part of State University of New York.

Dr. Blakely's NPI, 1811123722, was assigned on June 5, 2009. Dr. Blakely graduated from University of Maryland School of Medicine in 2009. Dr. Blakely holds New York license 284455.

Dr. Blakely's primary practice is Upstate University Hospital, at 750 East Adams Street, Syracuse, NY 13210 in Onondaga County. The practice phone is (315) 473-4240.

Dr. Blakely's primary practice is Upstate University Hospital in Syracuse, New York, part of State University of New York. Dr. Blakely is also affiliated with Wynn Hospital. The medical group on file is Upstate Urology. Dmand AI also links Dr. Blakely to 3 more hospitals, 1 therapy and rehab clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Blakely practices, 6 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Blakely's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dmand AI has Dr. Blakely's licenses on file in 2 states: New York and Colorado.

CMS data shows 594 Medicare services from Dr. Blakely across 9 procedure codes in 2024, for 369 Medicare patients. Medicare paid $30,869 for them.

CMS counts 369 Medicare patients who saw Dr. Blakely in 2024. The largest group is 65 to 74, with 128 patients. 75% of them have high blood pressure, and 69% have high cholesterol. 33% are also on Medicaid. Their average risk score is 2.16, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Blakely's median patient age at 63, with 33% women.

In 2024, Dr. Blakely wrote 1,683 Medicare Part D claims for 303 patients. 73% of them were for generic drugs. CMS names the drug for 1,601 of them, across 23 drugs with 11 or more claims each, at $228,332 in total drug cost. In 2023, CMS named 1,398 claims across 21 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Blakely for performance year 2024, reported as part of a group. Dr. Blakely accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Blakely as offering telehealth.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 11 papers to Dr. Blakely, published from 2014 to 2020. 2015 was the busiest year, with 3. The most frequent topics are Urethral Stricture, Urethra and Urologic Surgical Procedures, Male. Dr. Blakely has published most often in Int Urol Nephrol. Dr. Blakely's most frequent co-authors are Brian J. Flynn, MD, Krishnan Venkatesan, MD and Gennady Bratslavsky, MD.

Dmand AI links Dr. Blakely to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Prostatic Neoplasms and Prostatic Diseases.

CMS Open Payments shows 3 general payments to Dr. Blakely from 2 drug and device companies from 2018 to 2024. Education make up the largest share, 52% of the total. Ferring Pharmaceuticals Inc. paid the most, $26.

Dr. Blakely graduated from University of Maryland School of Medicine in 2009.